ScreenerHero
GXIGerresheimer AG
XETRA · DE · Healthcare · Medical Instruments & Supplies · gerresheimer.com
27.28EUR+0.22%Mkt Cap: 1.02B $P/E: —

Gerresheimer AG, together with its subsidiaries, provides drug containment solutions in Germany and internationally. The company operates through three divisions: Plastics & Devices, Primary Packaging Glass, and Advanced…

Industry Peers

Medical Instruments & Supplies
Screen all
ISRG
Intuitive Surgical, Inc.
$142.49BUSDP/E 45.6
EL
EssilorLuxottica Societe anonyme
$80.53BUSDP/E 30.2
BDX
Becton, Dickinson and Company
$51.10BUSDP/E 32.5
MDLN
Medline Inc. Class A Common Stock
$45.62BUSDP/E 42.4
ALC
Alcon AG
$32.71BUSDP/E 55.9
RMD
ResMed Inc.
$33.27BUSDP/E 22.1
WST
West Pharmaceutical Services, Inc.
$24.90BUSDP/E 45.4
DIM
Sartorius Stedim Biotech
$20.62BUSDP/E 64.6
SRT3
Sartorius Aktiengesellschaft
$18.68BUSDP/E 87.6
STMN
Straumann Holding AG
$17.47BUSDP/E 41.6
SRT
Sartorius Aktiengesellschaft
$15.01BUSDP/E 70.4
COLO-B
Coloplast A/S
$14.31BUSDP/E 35.6
SOLV
Solventum Corporation
$15.08BUSDP/E 10.8
COO
The Cooper Companies, Inc.
$14.85BUSDP/E 64.5
BAX
Baxter International Inc.
$13.77BUSD
ALGN
Align Technology, Inc.
$11.58BUSDP/E 28.3
RGEN
Repligen Corporation
$9.95BUSDP/E 241.6
AVTR
Avantor, Inc.
$9.44BUSD
ATR
AptarGroup, Inc.
$8.45BUSDP/E 24.0
YPSN
Ypsomed Holding AG
$6.15BUSDP/E 25.1

Key Statistics

Company
Market Cap1.02B $
Enterprise Value3.36B $
Revenue (TTM)2.52B $
Gross Profit462.23M $
Net Income (TTM)-348.17M $
Revenue/Share73.04 USD
Last Price27.28 EUR
Fiscal Year EndNov 2025
MR QuarterNov 2025
Employees13.5K
CountryDE
SectorHealthcare
IndustryMedical Instruments & Supplies
ISINDE000A0LD6E6
Valuation
P/E (Trailing)—
P/E (Forward)8.03
PEG1.23
EV/EBITDA8.63
EV/Revenue1.33
P/S0.41
P/B0.88
EPS (TTM)-9.27
EPS (Forward)3.41
52W Range
14.8339% of range46.72
52W High46.72 EUR
52W Low14.83 EUR
Profitability
Gross Margin18.32%
Oper. Margin4.95%
EBITDA Margin15.44%
Profit Margin-13.80%
ROE-29.63%
ROA-7.13%
Growth
Revenue Growth22.00%
Earnings Growth—
Cash Flow & Leverage
Operating CF227.75M $
CapEx (TTM)335.13M $
FCF Margin-18.33%
FCF Yield-45.24%
Net Debt2.31B $
Net Debt/EBITDA5.94
Balance Sheet
Debt/Equity2.01
Current Ratio0.81
Quick Ratio0.45
Book Value/Sh31.30 EUR
Cash/Share5.102 EUR
Dividends
Fwd Div Rate0.0400 EUR
Trail. Div Rate0.0000 EUR
Div. Yield0.15%
5Y Avg Yield1.36%
Payout Ratio5.88%
Ex-Div DateJun 6, 2025
Pay Date—
Analyst Consensus
Rating3.1 (Hold)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)27.05 EUR
Upside (mean)-0.9%
Target Range12.50 EUR – 46.00 EUR
€12.50-0.9% to mean€46.00
# Analysts11
Ownership
Shares Out.34.54M
Float32.05M
Insiders11.42%
Institutions74.39%
Technical
SMA 5027.32 (-0.1%)
SMA 20024.58 (+11.0%)
Beta0.47
S&P 52W Chg18.16%
Avg Vol (30d)167.94K
Avg Vol (10d)115.30K
Technical Indicators
RSI (14)49.3
MACD-0.0060
MACD Signal-0.0530
MACD Hist.+0.0470
BB Upper28.52 EUR
BB Middle27.17 EUR
BB Lower25.82 EUR
BB Width9.94%
ATR (14)1.277 EUR
Vol Ratio (20d)0.40x